Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.57 USD | -1.06% | +0.39% | -4.81% |
Evolution of the average Target Price on Syndax Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Syndax Pharmaceuticals, Inc.
JPMorgan Chase | |
Scotiabank | |
BofA Securities | |
HC Wainwright | |
Barclays | |
B. Riley | |
Stifel Nicolaus | |
Guggenheim | |
BTIG | |
Citigroup | |
Goldman Sachs | |
Morgan Stanley |
EPS Revisions
- Stock Market
- Equities
- SNDX Stock
- Consensus Syndax Pharmaceuticals, Inc.